Works by Busman, Todd

Results: 9

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors.

Published in:

2015

By:

Tolcher, Anthony;
LoRusso, Patricia;
Arzt, Jennifer;
Busman, Todd;
Lian, Guinan;
Rudersdorf, Niki;
Vanderwal, Carol;
Kirschbrown, Whitney;
Holen, Kyle;
Rosen, Lee;
Tolcher, Anthony W;
Busman, Todd A;
Rudersdorf, Niki S;
Vanderwal, Carol Ann;
Holen, Kyle D;
Rosen, Lee S

Publication type:

journal article

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study.

Published in:

2015

By:

Tolcher, Anthony;
LoRusso, Patricia;
Arzt, Jennifer;
Busman, Todd;
Lian, Guinan;
Rudersdorf, Niki;
Vanderwal, Carol;
Waring, Jeffrey;
Yang, Jianning;
Holen, Kyle;
Rosen, Lee;
Tolcher, Anthony W;
Busman, Todd A;
Rudersdorf, Niki S;
Vanderwal, Carol Ann;
Waring, Jeffrey F;
Holen, Kyle D;
Rosen, Lee S

Publication type:

journal article

Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.

Published in:

2024

By:

Cochrane, Tara;
Enrico, Alicia;
Gomez-Almaguer, David;
Hadjiev, Evgueniy;
Lech-Maranda, Ewa;
Masszi, Tamas;
Nikitin, Eugene;
Robak, Tadeusz;
Weinkove, Robert;
Wu, Shang-Ju;
Manzoor, Beenish S.;
Busman, Todd;
Pai, Madhavi;
Komlosi, Viktor;
Anderson, Mary Ann

Publication type:

Letter to the Editor

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.

Published in:

2007

By:

Gotfried M;
Busman TA;
Norris S;
Notario GF;
Gotfried, Mark;
Busman, Todd A;
Norris, Sandra;
Notario, Gerard F

Publication type:

journal article

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 2, p. 459, doi. 10.1185/030079906X162827

By:

Mark Gotfried;
Todd A. Busman;
Sandra Norris;
Gerard F. Notario

Publication type:

Article

Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae.

Published in:

Clinical Drug Investigation, 2003, v. 23, n. 8, p. 491, doi. 10.2165/00044011-200323080-00001

By:

Bonvehi, Paolo;
Weber, Katherine;
Busman, Todd;
Shortridge, Dee;
Notario, Gerard

Publication type:

Article

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20<sup>+</sup> lymphoid malignancies.

Published in:

British Journal of Haematology, 2015, v. 170, n. 5, p. 669, doi. 10.1111/bjh.13487

By:

Roberts, Andrew W.;
Advani, Ranjana H.;
Kahl, Brad S.;
Persky, Daniel;
Sweetenham, John W.;
Carney, Dennis A.;
Yang, Jianning;
Busman, Todd B.;
Enschede, Sari H.;
Humerickhouse, Roderick A.;
Seymour, John F.

Publication type:

Article

A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.

Published in:

Investigational New Drugs, 2014, v. 32, n. 5, p. 937, doi. 10.1007/s10637-014-0110-9

By:

Cleary, James;
Lima, Caio;
Hurwitz, Herbert;
Montero, Alberto;
Franklin, Catherine;
Yang, Jianning;
Graham, Alison;
Busman, Todd;
Mabry, Mack;
Holen, Kyle;
Shapiro, Geoffrey;
Uronis, Hope

Publication type:

Article

A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors.

Published in:

Investigational New Drugs, 2014, v. 32, n. 5, p. 976, doi. 10.1007/s10637-014-0116-3

By:

Vlahovic, Gordana;
Karantza, Vassiliki;
Wang, Ding;
Cosgrove, David;
Rudersdorf, Nikita;
Yang, Jianning;
Xiong, Hao;
Busman, Todd;
Mabry, Mack

Publication type:

Article